On Monday we published an article on Phase I clinical trial design.
#PhaseI #ClinicalResearch #DrugDevelopment #Biomarker #SmallMolecules #CRO #Pharma
@genelife.bsky.socialExplore
@genelife.bsky.social@genelife.bsky.socialPhase I: fewest patients, shortest duration, most consequential data in drug development.
Dose selection, PK profiling, safety characterization — every Phase III decision traces back here.